|
Jul 2026
As of Jul 31, 2026
|
Apr 2026
As of Apr 30, 2026
|
|
|---|---|---|
| Assets: | ||
| Cash | ||
| Prepaid expenses | ||
| Total Current Assets | ||
| Deferred offering costs | ||
| Investments held in Trust Account | ||
| Total Assets | ||
| Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | ||
| Current Liabilities | ||
| Accounts payable and accrued expenses | ||
| Due to related party | ||
| Promissory note – related party | ||
| Total Current Liabilities | ||
| Deferred underwriting fee payable | ||
| Total Liabilities | ||
| Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 10,500,000 shares at redemption value of $10.13 per share as of July 31, 2026 and 0 shares subject to possible redemption as of January 31, 2026 | ||
| Shareholders’ Deficit | ||
| Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 3,001,250(1)(2) shares and 2,875,000(1) shares issued and outstanding as of July 31, 2026 and January 31, 2026, respectively (excluding 10,500,000 and 0 shares subject to possible redemption as of July 31, 2026 and January 31, 2026, respectively) | ||
| Additional paid-in capital | ||
| Accumulated deficit | ||
| Total Shareholders’ Deficit | ||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
